Abbott's Aveir single chamber (VR) pacing system is the world's only leadless pacemaker with a unique mapping capability to assess correct positioning prior to placement Aveir VR has an increased ...

Abbott ABT recently received FDA approval for its pioneering AVEIR dual chamber (DR) leadless pacemaker system. The approval comes following the recent late-breaking clinical trial data showing that ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced that the FDA has approved its Aveir VR single-chamber leadless pacemaker for the treatment of ...

Though the FDA approval for Abbott’s first leadless pacemaker comes several years after its competitor Medtronic achieved the feat, the devicemaker is aiming to up the tempo. Like its peers in the ...

NEW ORLEANS, May 20, 2023 /PRNewswire/ -- Abbott today announced late-breaking results from the AVEIR™ dual-chamber (DR) i2i™ Investigational Device Exemption (IDE) study, a large-scale study to ...

NEW ORLEANS -- A leadless dual-chamber pacemaker with bidirectional wireless communication turned in very promising short-term results in patients with standard indications for dual-chamber pacing, ...

Abbott has taken a major step in the development of its dual-chamber leadless pacemaker technology, with the company’s first patient receiving two miniaturized, implanted devices within different ...

A wireless or leadless (without wires) pacemaker was implanted in a select group of children with irregular heart rhythms during a 5-year period (2016-2021). Smaller catheters that allow easier ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

Abbott's breakthrough technology enables the world's first beat-to-beat, wireless communication and synchronization between two leadless pacemakers, which are smaller than a AAA battery Leadless ...

International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals Far-Field Sensing and AV-Synchronous Pacing Performance Will be Validated by Real World Clinical Data ...